Costs and Healthcare Consumption in the Abdominally Obese Population
Radigue, C., Wolf, A., Allshouse, A. A., & Coste, F. (2005, November). Costs and Healthcare Consumption in the Abdominally Obese Population. Presented at ISPOR 8th Annual European Congress, Florence, Italy.
BACKGROUND• Abdominal obesity (AO) is positively correlated with a number of cardiometabolicrisk factors.• Little is known about the health and economic outcomes of weight loss innoninterventional and naturalistic settings.• None of the studies performed to date has focused on the AO population.• The Prospective Obesity Cohort of Economic Evaluation and Determinants(PROCEED) study is an ongoing cohort study of overweight or obesesubjects (body mass index [BMI] ³25 kg/m2) that will provide theopportunity to examine the healthcare consumption and costs inoverweight/obese individuals with or without AO.OBJECTIVE• To compare the healthcare consumption and costs associated withindividuals who are overweight/obese with or without AO against those ofa control group who are not overweight or obese (BMI 20–24 kg/m2) in theUSA, over the 3 months preceding baseline.– AO defined as waist circumference >102 cm for males and >88 cm forfemales (National Cholesterol Education Program's Adult TreatmentPanel III definition1).METHODSStudy design• PROCEED is an observational, prospective cohort study.• Subjects were recruited via the Internet.• Subjects were assigned to one of two groups dependent on their BMI:– Control group: BMI 20–24 kg/m2– Overweight/obese group: BMI ³25 kg/m2.• Inclusion criteria:– Aged ³35 and ²75 years– Able to give informed consent– Willing to disclose the name of their physician (at least 70% of thesubjects with a usual care provider), if any, for confirmation of theirmedical records– Subjects in the overweight/obese group had to be willing to start takingaction immediately to lose weight over the next 12 months.• Exclusion criteria:– Weight >180 kg (397 lb) (maximal capacity of scale)– Knowledge of pregnancy at baseline.